The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's Web site, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates. 22 Jun 2009  Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger 20 Jun 2009  Merck & Co., Inc. Statement on Medicare Part D Assistance 29 May 2009  Merck Statement on United States Patent & Trademark Office Decision to Reexamine the SINGULAIR® Patent 27 May 2009  Schering-Plough and Merck Provide Update on Distribution Agreement 11 May 2009  Merck & Co., Inc. Statement on Health Reform Meeting with President Obama 08 May 2009  Merck Statement on California Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for VIOXX® Costs 15 Apr 2009  Merck & Co., Inc. and Santen Sign Licensing Agreement In Ophthalmology 15 Apr 2009  Solar Energy Tapped to Power World Headquarters of Merck & Co., Inc. 30 Mar 2009  Court of Appeal for Saskatchewan Allows Merck's Appeal and Overturns Class Certification of Vioxx Action 23 Mar 2009  Merck & Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX® 23 Mar 2009  Merck Provides Update on Merger Financing 18 Mar 2009  Merck & Co., Inc. Donates Antimalarial Candidate to Medicines for Malaria Venture for Use in Developing World 17 Mar 2009  Merck Statement on New Jersey Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Out-of-Pocket VIOXX® Costs 09 Mar 2009  MERCK AND SCHERING-PLOUGH TO MERGE 25 Feb 2009  Dr. Thomas Cech Nominated to Join Merck Board of Directors 17 Feb 2009  Carlos E. Represas Elected to Merck Board of Directors 12 Feb 2009  Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed 02 Feb 2009  Dr. D. Gary Gilliland, Internationally-Recognized Physician and Researcher, Joins Merck Research Labs as Head of Oncology Research 08 Nov 2008  Merck Reaffirms Cardiovascular Research Commitment 12 Sep 2008  Star-Ledger Letter to the Editor from Dick Pasternak 09 Sep 2008  Federal Court of Appeals in a Divided Decision Reverses District Court Ruling Dismissing VIOXX® Securities Class Action 05 Sep 2008  NYT Letter to the Editor from Peter Kim 20 Aug 2008  NYT Letter to the Editor from Dick Clark 18 Aug 2008  The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting 17 Jul 2008  Merck to Fund U.S. VIOXX® Product Liability Resolution Program 15 Jul 2008  Leslie A. "Les" Brun Elected to Merck Board of Directors 11 Jul 2008  TREDAPTIVE™ (nicotinic acid /laropiprant) Approved in the European Union: New Lipid-Modifying Therapy to Treat LDL-C, HDL-C and Triglycerides 04 Jun 2008  New Jersey Supreme Court Dismisses Medical Monitoring Suit Filed by VIOXX® Plaintiffs 29 May 2008  Merck Wins Appeal of First VIOXX® Case to go to Trial 20 May 2008  Merck Resolves Investigations Under State Consumer Protection Statutes Related to VIOXX 14 May 2008  Merck Wins Appeal in VIOXX® Case 05 May 2008  Merck to Reduce U.S. Sales Force by 1,200 Positions 01 May 2008  Merck Extends Enrollment Deadline in Program to Resolve U.S. VIOXX® Product Liability Lawsuits 15 Apr 2008  Merck Responds to Journal of the American Medical Association Articles 03 Mar 2008  Merck Progress Report on Enrollment in Program to Resolve U.S. VIOXX® Product Liability Lawsuits 28 Feb 2008  Merck Retains Interest in AstraZeneca LP Products 07 Feb 2008  Merck Resolves Federal and State Investigations Related to Certain Past Pricing And Certain Past Sales and Marketing Activities 17 Dec 2007  Harry Jacobson, M.D., Elected to Merck Board of Directors 05 Dec 2007  World Bank and Merck & Co., Inc., Announce U.S. $50 Million Funding Initiative to Eliminate River Blindness in Africa 27 Nov 2007  Merck Announces First-Quarter 2008 Dividend 26 Nov 2007  Thomas H. Glocer Elected to Merck Board of Directors 26 Nov 2007  GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR® (lovastatin) from Merck & Co., Inc. 09 Nov 2007  Merck & Co., Inc. Conference Call and Audio Web Cast 09 Nov 2007  Merck Agreement to Resolve U.S. VIOXX® Product Liability Lawsuits 01 Nov 2007  The Merck/Merial Manual for Pet Health Gives Pet Owners a Trusted Reference for Keeping Their Animals Healthy and Happy 05 Oct 2007  Merck Wins Product Liability Case in Florida Circuit Court 27 Sep 2007  Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors 19 Sep 2007  Steven F. Goldstone Elected to Merck Board of Directors 17 Sep 2007  Merck & Co., Inc. Response to New York Medicaid Suit 11 Sep 2007  Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition 06 Sep 2007  New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking VIOXX® Reimbursements 26 Jul 2007  Merck Names Kenneth C. Frazier as President, Global Human Health 25 Jul 2007  Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates 12 Jul 2007  ARIAD and Merck & Co., Inc. Announce Global Collaboration to Jointly Develop and Commercialize AP23573 - ARIAD's Novel mTOR Inhibitor - for Cancer 29 Jun 2007  Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer 27 Jun 2007  SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement

*Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

Printer Friendly Page